Detection of 4‐CPA and Its Related Metabolites Based on LC‐QE‐HF‐MS Technology: A Study on the Impact of Doping Test on the Intake Pathways of Chlorphenesin Carbamate and Chlorphenesin
Rapid Communications in Mass Spectrometry · 2025
DOI: 10.1002/rcm.10004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Rapid Communications in Mass Spectrometry, 2025. Verfasst von Wennuo Xu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Anti-Doping Laboratory, Shanghai University of Sport, Shanghai, China. Hauptthemen laut MEDLINE: Mass Spectrometry, Substance Abuse Detection. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: Key Technologies R&D Program for Winter Olympic Games from Ministry of Science and Technology of the People's Republic of China.
Abstract (Originalsprache)
Objective
This study focused on meclofenoxate and its metabolite 4‐CPA in the field of doping control and examined the urinary metabolism of chlorphenesin carbamate and chlorphenesin, two substances that may produce 4‐CPA.
Methods
A liquid chromatography‐Q Exactive‐HF‐Orbitrap‐mass spectrometry (LC‐QE‐HF‐MS)–based assay was developed and validated for the accurate detection of the metabolites of 4‐CPA, chlorphenesin carbamate, and chlorphenesin and verified by human subject investigations. Human subjects were studied for three different modes of ingestion (chlorphenesin carbamate administration, sunscreen application containing chlorphenesin, and sunscreen spray application), and urine samples were collected before and after the administration to study the excretion profile of metabolites such as 4‐CPA.
Results
The developed assay meets the routine testing requirements of the World Anti‐Doping Agency. Following oral administration of chlorphenesin carbamate, 4‐CPA levels in the urine ranged from 390 to 6929 ng·mL −1 , reaching their maximum concentrations in 12–24 h, with two volunteers having values over the reporting limit. The highest excretion happened 12–24 h after the treatment and continued until 168–264 h later. The C max of 4‐CPA was 1354–2063 and 340 ng·mL −1 after application of sunscreen and spray sunscreen spray, respectively. Maximum excretion of other relevant metabolites was also concentrated at 12–24 h post‐dose.
Conclusion
The results suggest that when measuring 4‐CPA, the target analyte of meclofenoxate, in sports drug testing, special consideration needs to be given to whether volunteers have ingested normal therapeutic drugs, such as chlorphenesin carbamate, to avoid misreporting of meclofenoxate results. This finding offers crucial decision support for doping control.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shanghai Anti-Doping Laboratory, Shanghai University of Sport, Shanghai, China.
- School of Life Sciences, Shanghai University, Shanghai, China.
Förderung
- Key Technologies R&D Program for Winter Olympic Games from Ministry of Science and Technology of the People's Republic of China
Zitieren
APA
Xu, W., Cheng, J., Li, Z., Niu, B., Deng, X., & Liu, B. (2025). Detection of 4‐CPA and Its Related Metabolites Based on LC‐QE‐HF‐MS Technology: A Study on the Impact of Doping Test on the Intake Pathways of Chlorphenesin Carbamate and Chlorphenesin. Rapid Communications in Mass Spectrometry. https://doi.org/10.1002/rcm.10004
Vancouver
Xu W, Cheng J, Li Z, Niu B, Deng X, Liu B. Detection of 4‐CPA and Its Related Metabolites Based on LC‐QE‐HF‐MS Technology: A Study on the Impact of Doping Test on the Intake Pathways of Chlorphenesin Carbamate and Chlorphenesin. Rapid Communications in Mass Spectrometry. 2025. doi:10.1002/rcm.10004
BibTeX
@article{Xu2025,
author = {Xu, Wennuo and Cheng, Jiahui and Li, Zhongquan and Niu, Bing and Deng, Xiaojun and Liu, Bing},
title = {Detection of 4‐CPA and Its Related Metabolites Based on LC‐QE‐HF‐MS Technology: A Study on the Impact of Doping Test on the Intake Pathways of Chlorphenesin Carbamate and Chlorphenesin},
journal = {Rapid Communications in Mass Spectrometry},
year = {2025},
doi = {10.1002/rcm.10004}
}
EUVIMED